Comparing High-Protein and Low-Protein Multi-Ingredient Supplements for Body Composition and Performance in Elite Rugby Players
Comparison of High and Low Protein Dose With Multi-ingredient Supplementation for Body Composition and Exercise Performance in Elite Rugby Players
1 other identifier
interventional
20
1 country
1
Brief Summary
The purpose of this 12-week study is to compare the effects of two different post-exercise nutritional supplements on the body composition and exercise performance of elite male university rugby players. Athletes often consume very high amounts of protein to build muscle and recover, but excessive protein intake might pose potential health risks. Study Hypothesis: The researchers hypothesize that a multi-ingredient supplement with a lower total protein content (about 20 grams) will yield comparable or even superior improvements in body composition and physical performance compared to a standard high-dose whey protein supplement (40 grams). Study Design: Twenty elite male college rugby players will be randomly divided into two equal groups. One group will receive the high-dose whey protein, while the other group will receive the lower-dose multi-ingredient supplement (which includes protein, leucine, creatine, red amaranth, and elderberry). Participants will consume their assigned supplement immediately after their training sessions, four times a week for 12 weeks. Assessments: Before and after the 12-week intervention, the researchers will measure the participants' body composition (muscle and fat mass), maximum muscle strength, power, agility, and aerobic endurance. The overall goal is to determine if athletes can achieve optimal performance and muscle growth with a lower, more efficient protein intake strategy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 30, 2024
CompletedFirst Submitted
Initial submission to the registry
April 29, 2026
CompletedFirst Posted
Study publicly available on registry
May 6, 2026
CompletedMay 6, 2026
April 1, 2026
4 months
April 29, 2026
April 29, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Muscle Mass
Muscle mass is assessed using Dual-energy X-ray Absorptiometry (DXA). The change is evaluated by comparing the baseline values to the post-intervention values.
Baseline and Week 12
Study Arms (2)
High Protein Group
ACTIVE COMPARATORLow Protein Multi-Ingredient Group
EXPERIMENTALInterventions
Participants consume 40 g of Whey Protein Concentrate (WPC-80), providing 166 kcal, 32 g of protein, 5 g of carbohydrate, and 2 g of fat per serving. It is consumed immediately after training, four times per week for 12 weeks.
Participants consume a multi-ingredient supplement containing approximately 20 g of protein (whey protein fortified with additional leucine and glycine), 30 g of carbohydrates, creatine, red amaranth extract, and elderberry extract (169 kcal). It is consumed immediately after training, four times per week for 12 weeks.
Eligibility Criteria
You may qualify if:
- Elite rugby athletes in the university team No consumption of performance-enhancing supplements (e.g., creatine, protein supplements, or anabolic-androgenic steroids) one month prior to the study No current medication or major musculoskeletal injuries
You may not qualify if:
- Vegetarianism Whey protein allergy Body weight fluctuation of more than 10 kg in the past three months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Institute of Sports Sciences, University of Taipei
Taipei, 111036, Taiwan
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 29, 2026
First Posted
May 6, 2026
Study Start
November 30, 2023
Primary Completion
March 30, 2024
Study Completion
July 30, 2024
Last Updated
May 6, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share
To protect participant privacy, the sharing of individual participant data (IPD) was not included in the informed consent approved by the Institutional Review Board.